Skip to content

The effect of body composition on rocuronium pharmacology

The effect of body composition on rocuronium pharmacology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0004412
Enrollment
100
Registered
2019-11-01
Start date
2019-11-01
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Jeonbuk National University Hospital
Lead Sponsor
Jeonbuk National University Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: healty patients, aged 18 to 75 years, with ASA PS I or II undergoing elective surgery under general anesthesia for one hour or more

Exclusion criteria

Exclusion criteria: 1) patients anticipated diffilcult airway 2) patients with neuromuscular disease or taking medication 3) severe hepatic or renal impairment 4) drug allergy to rocuronium 5) patients undergoing major surgery anticipiated massive hemorrhage or transfusion during surgery 6) patient with implatable metal product, cardiac pacemaker or ICD 7) pregnat woman

Design outcomes

Primary

MeasureTime frame
onset of rocuronium

Secondary

MeasureTime frame
duration of rocuronium

Countries

Korea, Republic of

Contacts

Public ContactA Ram Doo

Jeonbuk National University

ruiwin3518@gmail.com+82-63-250-1241

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026